EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune-Related Proteomic Profiling in Clear Cell Renal Cell Carcinoma: Tissue and Soluble Biofluid Biomarkers

Christina Anatoliotaki, Sevastiani Antonouli, Vassilios Tzortzis, Panagiotis J Vlachostergios iD, Ioannis Zachos, Eleni Thodou, Antonis Giakountis iD, Maria Samara iD

International Journal of Molecular Sciences · 30.10.2026 · 27 (21) · 9764

DOI: 10.3390/ijms27219764 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2026. Verfasst von Christina Anatoliotaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biotechnology, School of Health Sciences, University of Thessaly, 41500 Larissa, Greece. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Biomarkers, Tumor, Proteomics, Kidney Neoplasms. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Thessaly, Public Investment Program of Greece "Thessaly 2021-2027" Program 2025ΕΠ00670029; OPS 6018577.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clear cell renal cell carcinoma (ccRCC) shows complex interactions with the tumor microenvironment, involving a range of immune checkpoint proteins and circulating biomarkers that may influence disease progression and response to treatment. Recent technological advances have identified tissue-based and circulating immune-related proteomic targets such as programmed death-ligand 1 (PD-L1), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and circulating interleukin-8 (cIL-8) as potential diagnostic, prognostic and predictive biomarkers. Despite significant progress, ccRCC remains a major clinical challenge due to its diverse molecular and immunological characteristics that hinder the clinical utility of these biomarkers. The present review provides an updated overview of the current evidence regarding immune-related proteomic biomarkers in ccRCC, including both tissue-derived and circulating proteins. Herein, we discuss the potential diagnostic, prognostic, and predictive value of such agents, emphasizing their biological significance and potential to guide personalized immunotherapeutic strategies. Particular attention is given to the developing liquid-biopsy-based techniques and their application as novel minimally invasive methods of identifying new targets for disease monitoring and treatment evaluation. Finally, we focus on emerging therapeutic approaches and combined strategies, highlighting how biomarker-driven precision oncology continues to reshape ccRCC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellBiomarkers, TumorProteomicsKidney NeoplasmsProteomeHumansPrognosisTumor Microenvironment

Stichwörter der Autor:innen

clear cell renal cell carcinomaimmune checkpoint proteinsimmune-related proteomic biomarkersliquid biopsy

Substanzen

Biomarkers, TumorProteome

Autor:innen und Institutionen

  • Department of Biochemistry and Biotechnology, School of Health Sciences, University of Thessaly, 41500 Larissa, Greece.
  • Department of Histology and Embryology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41500 Larissa, Greece.
  • Department of Urology, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, 41500 Larissa, Greece.
  • Department of Medical Oncology, Faculty of Medicine, School of Health Sciences, University Hospital of Ioannina, University of Ioannina, 45110 Ioannina, Greece.
  • Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY 10065, USA.
  • Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41500 Larissa, Greece.

ORCID-Profile: Panagiotis J Vlachostergios, Antonis Giakountis, Maria Samara

Förderung

  • University of Thessaly
  • Public Investment Program of Greece "Thessaly 2021-2027" Program 2025ΕΠ00670029; OPS 6018577

Zitieren

APA

Anatoliotaki, C., Antonouli, S., Tzortzis, V., Vlachostergios, P. J., Zachos, I., Thodou, E., Giakountis, A., & Samara, M. (2026). Immune-Related Proteomic Profiling in Clear Cell Renal Cell Carcinoma: Tissue and Soluble Biofluid Biomarkers. International Journal of Molecular Sciences, 27(21), 9764. https://doi.org/10.3390/ijms27219764

Vancouver

Anatoliotaki C, Antonouli S, Tzortzis V, Vlachostergios PJ, Zachos I, Thodou E, et al. Immune-Related Proteomic Profiling in Clear Cell Renal Cell Carcinoma: Tissue and Soluble Biofluid Biomarkers. International Journal of Molecular Sciences. 2026;27(21):9764. doi:10.3390/ijms27219764

BibTeX
@article{Anatoliotaki2026,
  author = {Anatoliotaki, Christina and Antonouli, Sevastiani and Tzortzis, Vassilios and Vlachostergios, Panagiotis J and Zachos, Ioannis and Thodou, Eleni and Giakountis, Antonis and Samara, Maria},
  title = {Immune-Related Proteomic Profiling in Clear Cell Renal Cell Carcinoma: Tissue and Soluble Biofluid Biomarkers},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9764},
  doi = {10.3390/ijms27219764}
}
Kostenlos starten →